[1]
A. Singh, A. Karnik, and A. Anand, “Prevalence of GATA-3 in invasive breast cancer and its significance in predicting response to neoadjuvant chemotherapy: a tertiary center experience”, Int Surg J, vol. 8, no. 6, pp. 1833–1838, May 2021.